Abstract
Schizophrenia and other schizophrenia spectrum disorders are chronic and debilitating psychiatric disorders that affect approximately 1% of the population. Individuals with these disorders often experience significant impairments in daily functioning. Childhood-onset schizophrenia is generally regarded as a schizophrenia disorder diagnosed before the age of 13. It is considered a rare and more severe form of schizophrenia compared to adult-onset schizophrenia. It is crucial for an accurate diagnosis and appropriate treatments to be implemented. This chapter will provide an overview of the diagnostic history, symptomology, associated impairments, developmental course, prognosis, and treatments associated with this disorder.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
American Academy of Child and Adolescent Psychiatry [AACAP]. (1998). Practice parameters for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. The Journal of American Academy of Child and Adolescent Psychiatry, 37(Suppl), 27S–45S.
American Academy of Child and Adolescent Psychiatry [AACAP]. (2001). Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. Journal of the American Academy of Child and Adolescent Psychiatry, 40(Suppl), 4S–23S.
American Psychiatric Association. (1968). Diagnostic and statistical manual of mental disorders (2nd ed.). Washington, DC: American Psychiatric Association.
American Psychiatric Association. (1980). Diagnostic and statistical manual of mental disorders (3rd ed.). Arlington, VA: American Psychiatric Association.
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Arlington, VA: American Psychiatric Association.
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Association.
Asarnow, J., Thompson, M., & Goldstein, M. (1994). Childhood-onset schizophrenia: A followup study. Schizophrenia Bulletin, 20, 599–617.
Asarnow, R., Nuechterlein, K., Fogelson, D., Subotnik, K., Payne, D., Russell, A., et al. (2001). Schizophrenia and schizophrenia-spectrum personality disorders in the first-degree relatives of children with schizophrenia: The UCLA family study. Archives of General Psychiatry, 58(6), 581–588.
Barrett, E., Sundet, K., Faerden, A., Agartz, I., Bratlien, U., Romm, K., et al. (2010). Suicidality in first episode psychosis is associated with insight and negative beliefs about psychosis. Schizophrenia Research, 123(2–3), 257–262.
Biswas, P., Malhotra, S., Malhotra, A., & Gupta, N. (2006). Comparative study of neuropsychological correlates in schizophrenia with onset in childhood, adolescence and adulthood. European Child and Adolescent Psychiatry, 15(6), 360–366.
Bunk, D., Eggers, C., & Klapal, M. (1999). Symptom dimensions in the course of childhood-onset schizophrenia. European Child and Adolescent Psychiatry, 8, 29–35.
Caplan, R. (1994). Communication deficits in childhood schizophrenia spectrum disorders. Schizophrenia Bulletin, 20(4), 671–683.
Carpenter, W., & Buchanan, R. (1994). Schizophrenia. The New England Journal of Medicine, 330, 681–690.
Cassano, C., Pini, S., Saettoni, M., Rucci, P., & Dell’Osso, L. (1998). Occurrence and clinical correlates of psychiatric comorbidity in patients with psychotic disorders. The Journal of Clinical Psychiatry, 59(2), 60–68.
Centorrino, F., Price, B., Tuttle, M., Bahk, W., Hennen, J., Albert, M., et al. (2002). EEG abnormalities during treatment with typical and atypical antipsychotics. American Journal of Psychiatry, 159(1), 109–115.
Dulmus, C., & Smyth, N. (2000). Early-onset schizophrenia: A literature review of empirically based interventions. Child and Adolescent Social Work Journal, 17, 55–69.
Eggers, C. (1978). Course and prognosis in childhood schizophrenia. Journal of Autism and Childhood Schizophrenia, 8(1), 21–36.
Eggers, C., Bunk, D., & Roepke, B. (2002). Childhood and adolescent schizophrenia: Results from two long-term follow-up studies. Neurology Psychiatry and Brain Research, 9, 183–190.
Garralda, M. (1984). Hallucinations in children with conduct and emotional disorders: II. The follow-up study. Psychological Medicine, 14(3), 597–604.
Giedd, J., Jeffries, N., Blumenthal, J., Castellanos, F., Vaituzis, A., Fernandez, T., et al. (1999). Childhood-onset schizophrenia: Progressive brain changes during adolescence. Biological Psychiatry, 46, 892–898.
Gogtay, N., Sporn, A., Clasen, L., Nugent, T., Greenstein, D., Nicolson, R., et al. (2004). Comparison of progressive cortical gray matter loss in childhood-onset schizophrenia with that in childhood-onset atypical psychoses. Archives of General Psychiatry, 61(1), 17–22.
Gonthier, M., & Lyon, M. (2004). Childhood-onset schizophrenia: An overview. Psychology in the Schools, 41(7), 803–811.
Greenstein, D., Lerch, J., Shaw, P., Clasen, L., Giedd, J., Gochman, P., et al. (2006). Childhood onset schizophrenia: Cortical brain abnormalities as young adults. Journal of Child Psychology and Psychiatry, 47(10), 1003–1012.
Haas, M., Unis, A., Armenteros, J., Copenhaver, M., Quiroz, J., & Kushner, S. (2009). A 6-week, randomized, double-blind, placebo-controlled study of the efficacy and safety of risperidone in adolescents with schizophrenia. Journal of Child and Adolescent Psychopharmacology, 19(6), 611–621.
Hollis, C. (2000). Adult outcomes of child- and adolescent-onset schizophrenia: Diagnostic stability and predictive validity. American Journal of Psychiatry, 157(10), 1652–1659.
Hugdahl, K., Loberg, E., & Nygard, M. (2009). Left temporal lobe structural and functional abnormality underlying auditory hallucinations in schizophrenia. Frontiers in Neuroscience, 3(1), 34–45.
Hummer, M., Kurz, M., Barnas, C., Saria, A., & Fleischhakker, W. (1994). Clozapine-induced transient white blood count disorders. The Journal of Clinical Psychiatry, 55(10), 429–432.
Jacobsen, L., Giedd, J., Berquin, P., Krain, A., Hamburger, S., Kumra, S., et al. (1997). Quantitative morphology of the cerebellum and fourth ventricle in childhood-onset schizophrenia. The American Journal of Psychiatry, 154(12), 1663–1669.
Jacobsen, L., & Rapoport, J. (1998). Childhood-onset schizophrenia: Implication of clinical and neurobiological research. Journal of Child Psychology and Psychiatry, 39(1), 101–103.
Kallmann, F., & Roth, B. (1956). Genetic aspects of pre-adolescent schizophrenia. American Journal of Psychiatry, 112, 599–606.
Kaufman, J., Birmaher, B., Brent, D., Rao, U., Flynn, C., Williamson, D., et al. (1997). Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): Initial reliability and validity data. Journal of American Academy of Child and Adolescent Psychiatry, 36(7), 980–988.
Kendler, K., McGuire, M., Gruenberg, A., O'Hare, A., Spellman, M., & Walsh, D. (1993). The Roscommon family study: I. Methods, diagnosis of probands, and risk of schizophrenia in relatives. Archives of General Psychiatry, 50(7), 527–540.
Kraguljac, N., White, D., Reid, M., & Lahti, A. (2013). Increased hippocampal glutamate and volumetric deficits in unmedicated patients with schizophrenia. JAMA Psychiatry, 70(12), 1294–1302.
Kumra, S., Frazier, J., Jacobsen, L. K., McKenna, K., Gordon, C. T., Lenane, M. C., et al. (1996). Childhood-onset schizophrenia. A double-blind clozapine-haloperidol comparison. Archives of General Psychiatry, 53(12), 1090–1097.
Kumra, S., Jacobsen, L., Lenane, M., Frazier, J., Smith, A., Bedwell, J., et al. (1998). Childhood-onset schizophrenia: An open-label study of olanzapine in adolescents. Journal of American Academy of Child and Adolescent Psychiatry, 37(4), 377–385.
Kumra, S., Wiggs, E., Bedwell, J., Smith, A., Arling, E., Albus, K., et al. (2000). Neuropsychological deficits in pediatric patients with childhood-onset schizophrenia and psychotic disorder not otherwise specified. Schizophrenia Research, 42, 135–144.
Lay, B., Blanz, B., Hartmann, M., & Schmidt, M. (2000). The psychosocial outcome of adolescent-onset schizophrenia: A 12-year followup. Schizophrenia Bulletin, 26, 801–816.
Lertxundi, U., Hernandez, R., Medrano, J., Domingo-Echaburu, S., Garcia, M., & Aguirre, C. (2013). Antipsychotics and seizures: Higher risk with atypicals? Seizure, 22(2), 141–143.
Lett, T., Voineskos, A., Kennedy, J., Levine, B., & Daskalakis, Z. (2014). Treating working memory deficits in schizophrenia: A review of the neurobiology. Biological Psychiatry, 75(5), 361–370.
Leucht, S., Tardy, M., Komossa, K., Heres, S., Kissling, W., Salanti, G., et al. (2012). Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: A systematic review and meta-analysis. Lancet, 379(9831), 2063–2071.
Lindsey, R., Kaplan, D., & Koliatsos, V. (2003). Aripiprazole and extrapyramidal symptoms. Journal of American Academy of Child and Adolescent Psychiatry, 42(11), 1268–1269.
Lopez, S., Nelson, H., Polo, A., Jenkins, J., Karno, M., Vaughn, C., et al. (2004). Ethnicity, expressed emotion, attributions, and course of schizophrenia: Family warmth matters. Journal of Abnormal Psychology, 11(3), 428–439.
Mattai, A., Hosanagar, A., Weisinger, B., Greenstein, D., Stidd, R., Clasen, L., et al. (2011). Hippocampal volume development in healthy siblings of childhood-onset schizophrenia patients. The American Journal of Psychiatry, 168(4), 427–435.
McClellan, J., McCurry, C., Snell, J., & Dubose, A. (1999). Early-onset psychotic disorders: Course and outcome over a 2-year period. Journal of American Academy of Child and Adolescent Psychiatry, 38(11), 1380–1388.
McClellan, J., Stock, S.; American Academy of Child and Adolescent Psychiatry [AACAP]. (2013). Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. Journal of American Academy of Child and Adolescent Psychiatry, 52(9), 976–990.
McConville, B., Carerro, L., Sweitzer, D., Potter, L., Chaney, R., Foster, K., et al. (2003). Long-term safety, tolerability, and clinical efficacy of quetiapine in adolescents: An open-label extension trial. Journal of Child and Adolescent Psychopharmacology, 13(1), 75–82.
McGrath, J., & Susser, E. (2009). New directions in the epidemiology of schizophrenia. The Medical Journal of Australia, 190(4 Suppl), S7–S9.
Mehler, C., & Warnke, A. (2002). Structural brain abnormalities specific to childhood-onset schizophrenia identified by neuroimaging techniques. Journal of Neural Transmission, 109(2), 219–234.
Moran, M., Weisinger, B., Ludovici, K., McAdams, H., Greenstein, D., Gochman, P., et al. (2013). At the boundary of the self: The insular cortex in patients with childhood-onset schizophrenia, their healthy siblings, and normal volunteers. International Journal of Developmental Neuroscience: The Official Journal of the International Society for Developmental Neuroscience, 32, 58–63.
Nicolson, R., Brookner, F., Lenane, M., Gochman, P., Ingraham, L., Egan, M., et al. (2003). Parental schizophrenia spectrum disorders in childhood-onset and adult-onset schizophrenia. American Journal of Psychiatry, 160(3), 490–495.
Nugent, T., Herman, D., Ordóñez, A., Greenstein, D., Hayashi, K., Lenane, M., et al. (2007). Dynamic mapping of hippocampal development in childhood onset schizophrenia. Schizophrenia Research, 90(1–3), 62–70.
Olabi, B., Ellison-Wright, I., McIntosh, A., Wood, S., Bullmore, E., & Lawrie, S. (2011). Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies. Biological Psychiatry, 70(1), 88–96.
Ordóñez, A., Sastry, N., & Gogtay, N. (2015). Functional and clinical insights from neuroimaging studies in childhood-onset schizophrenia. CNS Spectrums, 20(4), 442–450.
Pankow, A., Friedel, E., Sterzer, P., Seiferth, N., Walter, H., Heinz, A., et al. (2013). Altered amygdala activation in schizophrenia patients during emotion processing. Schizophrenia Research, 150(1), 101–106.
Rapoport, J., Chavez, A., Greenstein, D., Addington, A., & Gogtay, N. (2009). Autism-spectrum disorders and childhood onset schizophrenia: Clinical and biological contributions to a relationship revisited. Journal of American Academy of Child and Adolescent Psychiatry, 48(1), 10–18.
Rapoport, J., Giedd, J., & Gogtay, N. (2012). Neurodevelopmental model of schizophrenia: Update 2012. Molecular Psychiatry, 17(12), 1228–1238.
Regier, D., Narrow, W., Rae, D., Manderscheid, R., Locke, B., & Goodwin, F. (1993). The de facto US mental and addictive disorders service system: Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Archives of General Psychiatry, 50(2), 85–94.
Reichenberg, A., Caspi, A., Harrington, H., Houts, R., Keefe, R., Murray, R., et al. (2010). Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: A 30-year study. The American Journal of Psychiatry, 167(2), 160–169.
Remschmidt, H., Hennghausen, K., Clement, H., Heiser, P., & Schulz, E. (2000). Atypical neuroleptics in child and adolescent psychiatry. European Child and Adolescent Psychiatry, 9(Suppl 1), I9–I19.
Ross, R., Heinlein, S., & Tregellas, H. (2006). High rates of comorbidity are found in childhood-onset schizophrenia. Schizophrenia Research, 88, 90–95.
Ross, R., Novins, D., Farley, G., & Adler, L. (2003). A 1-year open-label trial of olanzapine in school-age children with schizophrenia. Journal of Child and Adolescent Psychopharmacology, 13(3), 301–309.
Shaw, P., Sporn, A., Gogtay, N., Greenstein, D., Gochman, P., Tossell, J., et al. (2006). Childhood-onset schizophrenia: A double-blind, randomized clozapine-olanzapine comparison. Archives of General Psychiatry, 63(7), 721–730.
Sikich, L., Hamer, R., Bashford, R., Sheitman, B., & Lieberman, J. (2004). A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: A double-blind, randomized, 8-week trial. Neuropsychopharmacology, 29(1), 133–145.
Spencer, E., & Campbell, M. (1994). Children with schizophrenia: Diagnosis, phenomenology and pharmacotherapy. Schizophrenia Bulletin, 20(4), 713–725.
Spencer, E., Kafantaris, V., Padron-Gayol, M., Rosenberg, C., & Campbell, M. (1992). Haloperidol in schizophrenic children: Early findings from a study in progress. Psychopharmacology Bulletin, 28(2), 183–186.
Sporn, A., Addington, A., Reiss, A., Dean, M., Gogtay, N., Potocnik, U., et al. (2004). 22q11 deletion syndrome in childhood onset schizophrenia: An update. Molecular Psychiatry, 9, 225–226.
Sporn, A., Vermani, A., Greenstein, D., Bobb, A., Spencer, E., Clasen, L., et al. (2007). Clozapine treatment of childhood-onset schizophrenia: Evaluation of effectiveness, adverse effects, and long-term outcome. Journal of American Academy of Child and Adolescent Psychiatry, 46(10), 1349–1355.
Sprooten, E., Papmeyer, M., Smyth, A., Vincenz, D., Honold, S., Conlon, G., et al. (2015). Cortical thickness in first-episode schizophrenia patients and individuals at high familial risk: A cross-sectional comparison. Schizophrenia Research, 151(1–3), 259–264.
Stafford, M., Mayo-Wilson, E., Loucas, C., James, A., Hollis, C., Birchwood, M., et al. (2015). Efficacy and safety of pharmacological and psychological interventions for the treatment of psychosis and schizophrenia in children, adolescents and young adults: A systematic review and meta-analysis. PLoS, 10(2), 1–17.
Toren, P., Ratner, S., Laor, N., & Weizman, A. (2004). Benefit-risk assessment of atypical antipsychotics in the treatment of schizophrenia and comorbid disorders in children and adolescents. Drug Safety, 27, 1135–1156.
Tsuang, M., Stone, W., & Faraone, S. (2000). Toward reformulating the diagnosis of schizophrenia. American Journal of Psychiatry, 157, 1041–1050.
Turetz, M., Mozes, T., Toren, P., Chernauzan, N., Yoran-Hegesh, R., Mester, R., et al. (1997). An open trial of clozapine in neuroleptic-resistant childhood-onset schizophrenia. The British Journal of Psychiatry: The Journal of Mental Science, 170, 507–510.
van Erp, T., Greve, D., Rasmussen, J., Turner, J., Calhoun, V., Young, S., et al. (2013). A multi-scanner study of subcortical brain volume abnormalities in schizophrenia. Psychiatry Research, 222(1–2), 10–16.
van Os, J., & Kapur, S. (2009). Schizophrenia. Lancet, 374(9690), 635–645.
Werry, J., McClellan, J., & Chard, L. (1991). Early onset schizophrenia, bipolar and schizoaffective disorders: A clinical follow up study. Journal of American Academy of Child and Adolescent Psychiatry, 30(3), 457–465.
Wylie, K., & Tregellas, J. (2010). The role of the insula in schizophrenia. Schizophrenia Research, 123(2–3), 93–104.
Yildiz, M., Borgwardt, S., & Berger, G. (2011). Parietal lobes in schizophrenia: Do they matter? Schizophrenia Research and Treatment, 2011, 581686.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Knorr, J. (2017). Childhood-Onset Schizophrenia Spectrum Disorders. In: Goldstein, S., DeVries, M. (eds) Handbook of DSM-5 Disorders in Children and Adolescents. Springer, Cham. https://doi.org/10.1007/978-3-319-57196-6_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-57196-6_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-57194-2
Online ISBN: 978-3-319-57196-6
eBook Packages: Behavioral Science and PsychologyBehavioral Science and Psychology (R0)